Balancing the healthcare needs and vastly differing ability to pay of patients and communities around the world is an increasingly challenging proposition in today's globalized economy. The pharmaceutical industry has a duty to ensure access to these lifesaving innovations, whilst maintaining and growing sustainable markets, which will help drive future innovations in the sector.

Session attendees will hear from industry leaders that are leading the fight to find new and innovative ways to achieve positive health outcomes in the world's most underserved populations, while at the same time managing to maintain and grow markets for the same products in both lower income and more developed economies. The topic of branded versus generic treatment options and the related pricing considerations and supply chain challenges will be covered to give a detailed picture of the precarious situation facing drug makers, and the people who rely on these lifesaving innovations.

Ability Level: All

Session ID: 503550